BUY ADVANCED TICKETS NOW to the latest Mikki Willis film including the festival premiere of Follow The Silenced. Join Mikki, Drea DeMatteo, Jimmy Levy, Jessica Sutta, Brianne Dressen and more for the screening and VIP reception.
For those old and new to this movement, make no mistake, this is a historic moment to celebrate Robert F Kennedy Jr.’s confirmation as Secretary of Health and Human Services!
We encourage you to act immediately! There’s no time to waste. Utilize our PERK Advocacy tool and send a message to the Senate Committees to vote yes on the nomination of Robert F Kennedy Jr to the Secretary of Health and Human Services.
Committee Hearings are starting late March. Check for updates on bills. Contact your legislator to vote “NO'“ or “Abstain” and submit your opposition letter to committees via legislative portal, 7 days prior to committee hearing. Go to our webpage for instructions on how to submit a legislative letter.
Download handout flyer.
Public health: immunizations - Keep Schools Open and Safe Act (Pan): Would require the COVID-19 vaccine to attend in-person daycare and K-12 public or private school, starting January 1 2023. It would also remove the personal belief exemption from future CDPH added vaccines and removes the 7th grade exemption for Hepatitis B.
Assigned: Senate Health and Education Committee
Talking points to oppose.
Please submit your letter of opposition to the Legislative Portal . Senate Health Committee entries are due by 12:00 noon on the Wednesday (March 9th, 2022) before the scheduled Health Committee hearing in order to be included on the bill analyses. SB871 can be heard as early as March, 16, 2022.
The committee has specific guidelines for when and how submissions are made, yet they are not announcing when the bill will be heard. Let’s be proactive. All you need is your name, email, and a few minutes.
There is one central portal with instructions for individuals and organizations. First, read directions below before going to the site: https://calegislation.lc.ca.gov/Advocates/
How to submit opposition/support letters to legislature for individuals:
1. Go to https://calegislation.lc.ca.gov/Advocates/
2. Click “Create an Account”. Minimum requirement is to provide your name and email address.
3. Log In
4. Enter Bill Number: SB 871 Public health: immunizations
5. Choose:
Session- (Regular)
Committee- (Check All Committees)
Stance- Please input “OPPOSE”. If you put in OPPOSE UNLESS AMENDED, your stance will not be listed in the legislative bill analysis. So, we ask you to input "OPPOSE”.
6. Optional- add a comment stating sound reasons why you oppose the bill.
________________________________________________
If you are an organization:
If you are head of an organization, group, chamber of commerce or union also register as organization and submit an official letter on letterhead from that entity.
Go to the Registration Page.
Select the No bubble next to “Are you a registered lobbyist?”
Complete the required fields in the User Details box.
Select the box labeled “I am affiliated with an organization.”
Begin typing the name of your Organization. Select your Organization from the dropdown that will appear as you type.
If your Organization does not return in the dropdown, select “Create a new Organization”.
Complete the Account Detail fields.
Complete the Captcha and Click “Register.”
Select measure type, measure number (BILL NUMBER) and Session Type.
Click on the “Search” button.
Select the appropriate Committees
Select Your Stance
Input note message in the note box.
Complete the Captcha and select the “Submit” button
For detailed directions on submitting a position letter: https://www.senate.ca.gov/sites/senate.ca.gov/files/2019_quick_ref_guide_advocacy.pdf
Letters must be on letterhead with signature and title of an official of the organization or designated representative.
Coalition letters must have logos, signatures, and titles for all organizations.
Letters of conditional support will not be listed on the analysis.
Letters must clearly indicate position (letters containing "concern" may not be listed).
Submit letters only once unless bill is subsequently amended causing uncertainty as to the organization's present position.
For more details on submitting a position letter:
Advocacy Quick Reference Guide - Position Letter Portal https://calegislation.lc.ca.gov/Advocates/
Stop FDA Approval of Pfizer Shots for Kids 6 Months to 4 Years. We have 5 days to stop the FDA. When you click submit, it will automatically send to all the decision-makers’ direct emails.
Take action and use this LINK
We have 5 days to stop the FDA. Comments received on or before February 10, 2022, will be provided to the committee. The FDA has now opened up formal comment for the Feb. 15 VRBPAC meeting. Please submit formal comments to the FDA.
Take action and submit comment here.
“Alert FDA, Stop, Do NOT Approve Pfizer Shots for Kids 6 Months to 4 Years
Previously, coronavirus trials failed in animals. When animal trials were skipped in 1960, infants post vaccination, got sicker when exposed to wild virus, including 80% of the vaccinated infants requiring hospitalization.
The clinical trial recently failed in this age group.”
Excellent Template Letter by Dr. Stephanie Sur. Use Sample Template Here. Here are 12 additional Sample Letters to FDA. Most of you will probably want to submit electronically here:
https://www.regulations.gov/search?filter=fda-2022-n-0082
FDA has established a docket for public comment on this meeting. The docket number is FDA-2022-N-0082. The docket will close on 11:59pm Eastern time on February 14, 2022.
Select Category: Individual Consumer or Health Professional. Submit comments by February 14, 2022. Late, untimely filed comments will not be considered.
State a few sentences or use templates here. Explain why the FDA must vote NO.
There is no emergency in this age group that would justify this use.
The clinical trial of the Pfizer vaccine failed in this age group.
You must vote NO because this proposed use violates the prohibitions against illegal medical experiments as outlined in the Nuremberg Code.
Read more details here if needed. Sample Letters to FDA
The PERK Team has confirmed through direct sources that this Call to Action is legitimate. Newsom's office is gathering data right now about potentially ending the child mask mandate. Help the children in California!
Call (916) 445-2841 to share your thoughts. (You can leave a recorded message if you'd like).
Press 1 for English. Press 6 Leave a message.
by Toby Rogers,PhD
UPDATE: The clinical trial failed in this age group. We have 5 days to stop the U.S. Food and Drug Administration from committing a crime against humanity. Comments received on or before February 10, 2022, will be provided to the committee.
The FDA has now opened up formal comment in connection with the Feb. 15 VRBPAC meeting:
FDA has established a docket for public comment on this meeting. The docket number is FDA-2022-N-0082. The docket will close on February 14, 2022. Submit either electronic or written comments on this public meeting by February 14, 2022. Please note that late, untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of February 14, 2022. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are received on or before that date.
https://www.regulations.gov/search?filter=fda-2022-n-0082
Select Category: Individual Consumer or Health Professional
A few sentences is fine. Simply explain why the FDA must vote NO. I like:
1. There is no emergency in this age group that would justify this use;
2. The clinical trial of the Pfizer vaccine failed in this age group; and
3. You must vote NO because this proposed use violates the prohibitions against illegal medical experiments as outlined in the Nuremberg Code.
Pfizer announcement wants their disastrous mRNA shot added to the official schedule for children so that they can have liability protection forever.
The Pfizer mRNA shot in children 2- to 4-years old failed in the clinical trial.
Acting FDA Commissioner, Janet Woodcock, following orders from the Biden administration said, (I’m paraphrasing here) ‘don’t worry about the fact that the shot does not work, we’ve got a drug to sell, submit an Emergency Use Authorization (EUA) application anyway.’
So Tuesday (Feb. 1) Pfizer submitted an EUA application for children six-months to four-years old.
Pfizer and the FDA are proposing to start with two shots in this age group even though that approach has already failed and then they will add a third dose later in the spring if data comes in that supports that use. The plan is literally — shoot up kids first, get the data later. This approach is completely unprecedented in the history of the FDA and it must be stopped.
The FDA’s Vaccines and Related Biological Products Advisory Committee will meet in two weeks — on February 15 — to evaluate this EUA application for a product that failed the clinical trial.
So warriors, you know what to do. I need you to get on the phone, get your fax machines humming, and start sending out emails like the future of this country depends on it — because it does. Physical paper letters sent in the next couple days via the U.S. Postal Service will probably get there in time too.
In October we generated tens of thousands of calls, emails, and faxes. Our goal in the next two weeks must be to generate hundreds of thousands of calls, emails, faxes, and letters.
The message we need to send to these bureaucrats is — ABSOLUTELY NOT! Every single person who plays a role in this decision needs to get the message that:
1. We are watching;
2. The clinical trial of the Pfizer vaccine failed in this age group; and
3. You must vote NO because this proposed use violates the prohibitions against illegal medical experiments as outlined in the Nuremberg Code.
Anyone who goes along with Janet Woodcock’s bullying on behalf of the cartel will be prosecuted for crimes against humanity.
It’s hard to know exactly who will be at the VRBPAC meeting because the FDA uses Temporary Voting Members and the VRBPAC has not met since we exposed them as frauds back in October (when they rubber stamped Pfizer’s EUA application for kids 5 to 11 in spite of no data showing clinical effectiveness). But the best guess is that the voting members will be roughly the same as the last meeting so that is who we are reaching out to now.
Here are the 23 people we need to reach before Tuesday, February 15:
Janet Woodcock
Acting FDA Commissioner
FDA, mail stop: HFD-001
10903 New Hampshire Ave., WO51-6133
Silver Spring MD 20993-0002
phone: (301) 796-5400
fax: (301) 847-8752
Janet.Woodcock@fda.hhs.gov
https://twitter.com/DrWoodcockFDA
Rochelle Walensky
Director, Centers for Disease Control and Prevention
Roybal Building 21, Rm 12000
1600 Clifton Rd
Atlanta, GA 30333
phone: (404) 639-7000
Aux7@cdc.gov
https://twitter.com/CDCDirector
Xavier Becerra
Secretary, Health & Human Services
200 Independence Avenue S.W.
Washington, D.C. 20201
c/o Sean McCluskie
sean.mccluskie@hhs.gov
https://twitter.com/XavierBecerra
Peter Marks
Director, Center for Biologics Evaluation and Research
FDA, Mail stop: HFM-2
10903 New Hampshire Ave., WO71-7232
Silver Spring MD 20993-0002
phone: (240) 402-8116
fax: (301) 595-1310
Peter.Marks@fda.hhs.gov
Acting Chair, VRBPAC
Arnold Monto, M.D.
Professor of Public Health & Epidemiology
Department of Epidemiology
University of Michigan School of Public Health
Ann Arbor, MI 48109
phone: (734) 764-5453
fax: (734) 764-3192
asmonto@umich.edu
Paula Annunziato, M.D.
Vice President and Therapeutic Area Head
Vaccines Clinical Research
Merck
North Wales, PA 19454
paula.annunziato@merck.com
Captain Amanda Cohn
Chief Medical Officer
National Center for Immunizations and Respiratory Diseases
Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 MS C-09
phone: (404) 639-6039
fax: (404) 315-4679
acohn@cdc.gov
anc0@cdc.gov
Hayley Gans, M.D.
Professor of Pediatrics
Department of Pediatrics
Stanford University Medical Center
Stanford, CA 94305
phone: (650) 723-5682
fax: (650) 725-8040
hgans@stanford.edu
Michael Kurilla, M.D., Ph.D.
Director, Division of Clinical Innovation
National Center for Advancing Translation Sciences
National Institutes of Health
Bethesda, MD 20852
phone: (301) 435-0178
Michael.kurilla@nih.gov
H. Cody Meissner, M.D.
Professor of Pediatrics
Tufts University School of Medicine
Director, Pediatric Infectious Disease
Tufts Medical Center
Boston, MA 02111
phone: (617) 636-5227
fax: (617) 636-4300
cmeissner@tuftsmedicalcenter.org
Paul Offit, M.D.
Professor of Pediatrics
Division of Infectious Diseases
Abramson Research Building
The Children’s Hospital of Philadelphia
Philadelphia, PA 19104
phone: (215) 590-2020
offit@chop.edu
https://twitter.com/DrPaulOffit
Steven Pergam, M.D.
Medical Director
Infection Prevention
Seattle Cancer Care Alliance
Seattle, WA 98109
phone: (206) 667-7126
spergam@fredhutch.org
https://twitter.com/PergamIC
Temporary Voting Members (but their votes count all the same)
A. Oveta Fuller, Ph.D.
Associate Professor of Microbiology and Immunology,
University of Michigan Medical School
Ann Arbor, MI 48109
phone: (734) 647-3830
fullerao@umich.edu
James Hildreth, Sr., Ph.D., M.D.
Professor
Department of Internal Medicine
School of Medicine
President and Chief Executive Officer
Meharry Medical College
Nashville, TN 37205
officeofthepresident@mmc.edu
https://twitter.com/JamesEKHildreth
Jeannette Lee, Ph.D.
Professor Department of Biostatistics
University of Arkansas for Medical Sciences
Little Rock, AR 72701
phone: (501) 526-6712
JYLee@uams.edu
Ofer Levy, M.D., Ph.D.
Staff Physician & Principal Investigator
Director, Precision Vaccines Program
Division of Infectious Diseases
Boston Children’s Hospital
Harvard Medical School Associate Member
phone: (617) 919-2900
fax: (617) 730-0254
ofer.levy@childrens.harvard.edu
https://twitter.com/levy_o
Patrick Moore, M.D., M.P.H.
Distinguished and American Cancer Society Professor
Pittsburgh Foundation Chair in Innovative Cancer Research
University of Pittsburgh Cancer Institute
Pittsburgh, PA 15213
phone: (412) 623-7721
psm9@pitt.edu
Michael Nelson, M.D., Ph.D.
Professor of Medicine
Asthma, Allergy and Immunology Division
UVA Division of Asthma, Allergy & Immunology
PO Box 801355
Charlottesville, VA 22908
phone: (434) 297-8399
fax: (434) 924-5779
mrn8d@virginia.edu
Stanley Perlman, M.D., Ph.D.
Professor of Pediatrics
University of Iowa
3-712 Bowen Science Building (BSB)
51 Newton Rd
Iowa City, IA 52242
phone: (319) 335-8549
stanley-perlman@uiowa.edu
Jay Portnoy, M.D.
Director,
Division of Allergy, Asthma & Immunology
Children’s Mercy Hospitals & Clinics
2401 Gillham Road Kansas City, MO 64108
phone: (816) 960-8885
fax: (816) 960-8888
Jportnoy@cmh.edu
Eric Rubin, M.D., Ph.D.
Editor-in-Chief
New England Journal of Medicine
Adjunct Professor
Harvard TH Chan School of Public Health
665 Huntington Ave
Building 1, Room 811
Boston, MA 02115
phone: (617) 432-3335
erubin@hsph.harvard.edu
erubin@nejm.org
Mark Sawyer, M.D.
Professor of Clinical Pediatrics
8110 Birmingham Way
Bldg. 28, 1st Floor
San Diego, CA 92123
phone: (858) 966-7785
fax: (858) 966-8658
mhsawyer@health.ucsd.edu
Melinda Wharton, M.D., MPH
Associate Director for Vaccine Policy
National Center for Immunization and Respiratory Diseases,
Centers for Disease Control and Prevention,
1600 Clifton Road, Mailstop E05,
Atlanta, GA 30333
phone: (404) 639.8755
fax: (404) 639.8626
mew2@cdc.gov
Please be respectful and courteous. Let’s do this! 🙌
Subscribe to our newsletter.
